Advertisement
Screener

AngioDynamics, Inc. (ANGO) Cash and Cash Equivalents, Period Increase (Decrease)

1.7 / 5 stars · 26/77 Roast Me

AngioDynamics, Inc. Cash and Cash Equivalents, Period Increase (Decrease)

AngioDynamics, Inc. (ANGO) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$200.48 million for the 9-month period ending 2020-02-29, per its 10-Q filed 2020-04-08.

Discontinued › Cash Flow › Change in Cash

us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2020-04-08

  • AngioDynamics, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2020-02-29 was -$14.09M.
  • AngioDynamics, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-11-30 was -$42.40M, a 334.81% decline year-over-year.
  • AngioDynamics, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-08-31 was -$143.99M.
  • AngioDynamics, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-05-31 was $185.94M, a 752.77% increase year-over-year.
  • AngioDynamics, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2019 was $153.54M, a 478.28% increase from fiscal 2018.
  • AngioDynamics, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2018 was $26.55M, a 74.56% increase from fiscal 2017.
  • AngioDynamics, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $15.21M, a 9.10% increase from fiscal 2016.
  • AngioDynamics, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2016 was $13.94M, a 509.89% increase from fiscal 2015.
Period endCash and Cash Equivalents, Period Increase (Decrease) 3 monthCash and Cash Equivalents, Period Increase (Decrease) 6 monthCash and Cash Equivalents, Period Increase (Decrease) 9 monthCash and Cash Equivalents, Period Increase (Decrease) 12 monthCash and Cash Equivalents, Period Increase (Decrease) 12 month as first filed
2020-02-29-$14.09M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-04-08
-$56.49M
derived: sum of 2 quarters · filed 2020-04-08
-$200.48M
10-Q · filed 2020-04-08
-$14.54M
derived: sum of 4 quarters · filed 2020-04-08
2019-11-30-$42.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-01-08
-$186.39M
10-Q · filed 2020-01-08
-$457.00K
derived: sum of 3 quarters · filed 2020-01-08
-$1.57M
derived: sum of 4 quarters · filed 2020-04-08
2019-08-31-$143.99M
10-Q · filed 2019-10-04
$41.95M
derived: sum of 2 quarters · filed 2019-10-04
$40.83M
derived: sum of 3 quarters · filed 2020-04-08
$58.89M
derived: sum of 4 quarters · filed 2020-04-08
2019-05-31$185.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-25
$184.82M
derived: sum of 2 quarters · filed 2020-04-08
$202.88M
derived: sum of 3 quarters · filed 2020-04-08
$153.54M
10-K · filed 2019-07-25
2019-02-28-$1.12M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-04-08
$16.94M
derived: sum of 2 quarters · filed 2020-04-08
-$32.39M
10-Q · filed 2020-04-08
-$10.59M
derived: sum of 4 quarters · filed 2020-04-08
2018-11-30$18.06M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-01-08
-$31.28M
10-Q · filed 2020-01-08
-$9.47M
derived: sum of 3 quarters · filed 2020-01-08
-$7.04M
derived: sum of 4 quarters · filed 2020-01-08
2018-08-31-$49.33M
10-Q · filed 2019-10-04
-$27.53M
derived: sum of 2 quarters · filed 2019-10-04
-$25.09M
derived: sum of 3 quarters · filed 2019-10-04
-$23.44M
derived: sum of 4 quarters · filed 2019-10-04
2018-05-31$21.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-25
$24.24M
derived: sum of 2 quarters · filed 2019-07-25
$25.90M
derived: sum of 3 quarters · filed 2019-07-25
$26.55M
10-K · filed 2019-07-25
2018-02-28$2.44M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-04-02
$4.09M
derived: sum of 2 quarters · filed 2019-04-02
$4.75M
10-Q · filed 2019-04-02
$16.72M
derived: sum of 4 quarters · filed 2019-07-25
2017-11-30$1.66M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-01-07
$2.31M
10-Q · filed 2019-01-07
$14.29M
derived: sum of 3 quarters · filed 2019-07-25
$14.19M
derived: sum of 4 quarters · filed 2019-07-25
2017-08-31$656.00K
10-Q · filed 2018-10-01
$12.63M
derived: sum of 2 quarters · filed 2019-07-25
$12.54M
derived: sum of 3 quarters · filed 2019-07-25
$10.79M
derived: sum of 4 quarters · filed 2019-07-25
2017-05-31$11.97M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-25
$11.88M
derived: sum of 2 quarters · filed 2019-07-25
$10.13M
derived: sum of 3 quarters · filed 2019-07-25
$15.21M
10-K · filed 2019-07-25
2017-02-28-$93.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-04-05
-$1.84M
derived: sum of 2 quarters · filed 2018-04-05
$3.24M
10-Q · filed 2018-04-05
$13.67M
derived: sum of 4 quarters · filed 2018-07-23
2016-11-30-$1.75M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-05
$3.33M
10-Q · filed 2018-01-05
$13.77M
derived: sum of 3 quarters · filed 2018-07-23
$16.67M
derived: sum of 4 quarters · filed 2018-07-23
2016-08-31$5.08M
10-Q · filed 2017-09-29
$15.51M
derived: sum of 2 quarters · filed 2018-07-23
$18.41M
derived: sum of 3 quarters · filed 2018-07-23
$17.14M
derived: sum of 4 quarters · filed 2018-07-23
2016-05-31$10.44M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-23
$13.34M
derived: sum of 2 quarters · filed 2018-07-23
$12.06M
derived: sum of 3 quarters · filed 2018-07-23
$13.94M
10-K · filed 2018-07-23
2016-02-29$2.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-04-03
$1.63M
derived: sum of 2 quarters · filed 2017-04-03
$3.51M
10-Q · filed 2017-04-03
$2.19M
derived: sum of 4 quarters · filed 2017-08-04
2015-11-30-$1.27M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-01-06
$605.00K
10-Q · filed 2017-01-06
-$708.00K
derived: sum of 3 quarters · filed 2017-08-04
$4.12M
derived: sum of 4 quarters · filed 2017-08-04
2015-08-31$1.88M
10-Q · filed 2016-10-05
$564.00K
derived: sum of 2 quarters · filed 2017-08-04
$5.39M
derived: sum of 3 quarters · filed 2017-08-04
$6.46M
derived: sum of 4 quarters · filed 2017-08-04
2015-05-31-$1.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-04
$3.51M
derived: sum of 2 quarters · filed 2017-08-04
$4.58M
derived: sum of 3 quarters · filed 2017-08-04
$2.29M
10-K · filed 2017-08-04
2015-02-28$4.83M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-04-11
$5.90M
derived: sum of 2 quarters · filed 2016-04-11
$3.60M
10-Q · filed 2016-04-11
$12.32M
derived: sum of 4 quarters · filed 2016-08-01
2014-11-30$1.07M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-01-08
-$1.23M
10-Q · filed 2016-01-08
$7.50M
derived: sum of 3 quarters · filed 2016-08-01
-$296.00K
derived: sum of 4 quarters · filed 2016-08-01
2014-08-31-$2.30M
10-Q · filed 2015-10-08
$6.43M
derived: sum of 2 quarters · filed 2016-08-01
-$1.36M
derived: sum of 3 quarters · filed 2016-08-01
-$8.26M
derived: sum of 4 quarters · filed 2016-08-01
2014-05-31$8.72M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-01
$932.00K
derived: sum of 2 quarters · filed 2016-08-01
-$5.96M
derived: sum of 3 quarters · filed 2016-08-01
-$5.70M
10-K · filed 2016-08-01
2014-02-28-$7.79M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-09
-$14.68M
derived: sum of 2 quarters · filed 2015-04-09
-$14.42M
10-Q · filed 2015-04-09
-$9.47M
derived: sum of 4 quarters · filed 2015-08-10
2013-11-30-$6.89M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-01-09
-$6.63M
10-Q · filed 2015-01-09
-$1.68M
derived: sum of 3 quarters · filed 2015-08-10
-$4.38M
derived: sum of 4 quarters · filed 2015-08-10
2013-08-31$263.00K
10-Q · filed 2014-10-15
$5.21M
derived: sum of 2 quarters · filed 2015-08-10
$2.51M
derived: sum of 3 quarters · filed 2015-08-10
$2.94M
derived: sum of 4 quarters · filed 2015-08-10
2013-05-31$4.95M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-10
$2.25M
derived: sum of 2 quarters · filed 2015-08-10
$2.67M
derived: sum of 3 quarters · filed 2015-08-10
-$1.94M
10-K · filed 2015-08-10
-$1.71M
10-K · filed 2013-08-14
2013-02-28-$2.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-04-09
-$2.27M
derived: sum of 2 quarters · filed 2014-04-09
-$6.88M
10-Q · filed 2014-04-09
-$17.19M
derived: sum of 4 quarters · filed 2015-01-12
2012-11-30$426.00K
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-01-09
-$4.19M
10-Q · filed 2013-01-09
-$14.49M
derived: sum of 3 quarters · filed 2015-01-12
-$23.40M
derived: sum of 4 quarters · filed 2015-01-12
2012-08-31-$4.61M
10-Q/A · filed 2012-11-09
-$14.92M
derived: sum of 2 quarters · filed 2015-01-12
-$23.83M
derived: sum of 3 quarters · filed 2015-01-12
-$31.37M
derived: sum of 4 quarters · filed 2015-01-12
2012-05-31-$10.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-12
-$19.22M
derived: sum of 2 quarters · filed 2015-01-12
-$26.75M
derived: sum of 3 quarters · filed 2015-01-12
-$22.25M
10-K · filed 2015-01-12
-$22.48M
10-K · filed 2012-08-14
2012-02-29-$8.91M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-04-09
-$16.45M
derived: sum of 2 quarters · filed 2013-04-09
-$11.94M
10-Q · filed 2013-04-09
-$1.21M
derived: sum of 4 quarters · filed 2013-08-14
2011-11-30-$7.54M
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-01-09
-$3.03M
10-Q · filed 2013-01-09
$7.70M
derived: sum of 3 quarters · filed 2013-08-14
$15.82M
derived: sum of 4 quarters · filed 2013-08-14
2011-08-31$4.51M
10-Q/A · filed 2012-11-09
$15.24M
derived: sum of 2 quarters · filed 2013-08-14
$23.36M
derived: sum of 3 quarters · filed 2013-08-14
-$16.71M
derived: sum of 4 quarters · filed 2013-08-14
2011-05-31$10.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-14
$18.85M
derived: sum of 2 quarters · filed 2013-08-14
-$21.22M
derived: sum of 3 quarters · filed 2013-08-14
-$12.78M
10-K · filed 2013-08-14
2011-02-28$8.13M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-04-09
-$31.95M
derived: sum of 2 quarters · filed 2012-04-09
-$23.51M
10-Q · filed 2012-04-09
2010-11-30-$40.07M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-01-05
-$31.63M
10-Q · filed 2012-01-05
2010-08-31$8.44M
10-Q · filed 2011-10-11
2010-05-31$30.85M
10-K · filed 2012-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B
SS Innovations International, Inc. (SSII)$0.589B-64.06
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33
CERUS CORP (CERS)United States$0.525B-86.40
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16
NeuroPace Inc (NPCE)United States$0.480B-28.52
Sight Sciences, Inc. (SGHT)United States$0.478B-9.95
ClearPoint Neuro, Inc. (CLPT)United States$0.446B-15.74
SI-BONE, Inc. (SIBN)United States$0.830B-49.82